ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Minnesota » Ophthalmology

Top Ophthalmology Prescribers in Minnesota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STANLEY WALKER MD

Ophthalmology

5,225

$349K

909
867 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

66%
prescriptions for brand name drugs

Avg: 56%

$67
Average prescription price

Avg: $61

PATRICK RIEDEL M.D.

Ophthalmology

5,032

$318K

813
748 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

65%
prescriptions for brand name drugs

Avg: 56%

$63
Average prescription price

Avg: $61

THOMAS SAMUELSON M.D.

Ophthalmology

4,579

$316K

775
717 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

66%
prescriptions for brand name drugs

Avg: 56%

$69
Average prescription price

Avg: $61

ERIC STEFFEN M.D.

Ophthalmology

4,538

$338K

599
558 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

66%
prescriptions for brand name drugs

Avg: 56%

$74
Average prescription price

Avg: $61

RICHARD STANEK M.D.

Ophthalmology

4,456

$290K

784
748 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

59%
prescriptions for brand name drugs

Avg: 56%

$65
Average prescription price

Avg: $61

JOHN BERESTKA MD

Ophthalmology

4,451

$264K

810
760 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

66%
prescriptions for brand name drugs

Avg: 56%

$59
Average prescription price

Avg: $61

KEVIN TREACY MD

Ophthalmology

3,856

$197K

690
651 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

53%
prescriptions for brand name drugs

Avg: 56%

$51
Average prescription price

Avg: $61

CARTER NICHOLS M.D.

Ophthalmology

3,769

$209K

734
690 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

64%
prescriptions for brand name drugs

Avg: 56%

$55
Average prescription price

Avg: $61

DAVID HARDTEN M.D.

Ophthalmology

3,741

$382K

589
536 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 3%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

73%
prescriptions for brand name drugs

Avg: 56%

$102
Average prescription price

Avg: $61

DAVID SABIR M.D.

Ophthalmology

3,450

$143K

738
690 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 3%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

54%
prescriptions for brand name drugs

Avg: 56%

$41
Average prescription price

Avg: $61

MARK SHANFELD M.D.

Ophthalmology

3,378

$237K

615
587 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

80%
prescriptions for brand name drugs

Avg: 56%

$70
Average prescription price

Avg: $61

ALAN SADOWSKY M.D.

Ophthalmology

3,354

$135K

627
591 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

44%
prescriptions for brand name drugs

Avg: 56%

$40
Average prescription price

Avg: $61

ELIZABETH DAVIS M.D.

Ophthalmology

3,320

$225K

662
609 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

78%
prescriptions for brand name drugs

Avg: 56%

$68
Average prescription price

Avg: $61

TIMOTHY GESS M.D.

Ophthalmology

3,114

$173K

538
516 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

63%
prescriptions for brand name drugs

Avg: 56%

$56
Average prescription price

Avg: $61

LEONID SKORIN D.O.

Ophthalmology

3,072

$162K

503
481 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

61%
prescriptions for brand name drugs

Avg: 56%

$53
Average prescription price

Avg: $61

STEVEN THOM MD

Ophthalmology

2,980

$221K

579
555 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

72%
prescriptions for brand name drugs

Avg: 56%

$74
Average prescription price

Avg: $61

DAN NICHOLS M.D.

Ophthalmology

2,922

$192K

594
563 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

62%
prescriptions for brand name drugs

Avg: 56%

$66
Average prescription price

Avg: $61

CARL TUBBS M.D.

Ophthalmology

2,833

$216K

544
514 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

65%
prescriptions for brand name drugs

Avg: 56%

$76
Average prescription price

Avg: $61

JOHN HOINES MD

Ophthalmology

2,802

$135K

472
449 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

55%
prescriptions for brand name drugs

Avg: 56%

$48
Average prescription price

Avg: $61

PATRICK JOHNSON M.D.

Ophthalmology

2,767

$180K

529
491 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

52%
prescriptions for brand name drugs

Avg: 56%

$65
Average prescription price

Avg: $61

SUSAN RELF MD

Ophthalmology

2,707

$140K

467
449 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

50%
prescriptions for brand name drugs

Avg: 56%

$52
Average prescription price

Avg: $61

TIMOTHY EHLEN MD

Ophthalmology

2,692

$184K

539
510 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

76%
prescriptions for brand name drugs

Avg: 56%

$68
Average prescription price

Avg: $61

SHERMAN REEVES MD

Ophthalmology

2,657

$244K

550
484 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

76%
prescriptions for brand name drugs

Avg: 56%

$92
Average prescription price

Avg: $61

SCOTT UTTLEY M.D.

Ophthalmology

2,644

$185K

472
434 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

61%
prescriptions for brand name drugs

Avg: 56%

$70
Average prescription price

Avg: $61

ARTHUR SIT M.D.

Ophthalmology

2,643

$175K

374
356 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

57%
prescriptions for brand name drugs

Avg: 56%

$66
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank